Dianthus Therapeutics, Inc. (DNTH) earnings
DNTH earnings moved a median of +0.23% by the close. Quarterly and annual DNTH reports and results, each read against the price at its own news timestamp. Back to the DNTH overview →
11 measured DNTH earnings events.
Where these DNTH earnings landedvs 11 measured DNTH earnings reactions
| Middle 50% of DNTH earnings reactions | -2.60% to +2.11% |
|---|---|
| Median reaction (to close) | +0.23% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 DNTH earnings events with a measured close landed between -2.60% and +2.11%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Dianthus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.81% | +2.38% | |
| Form 10-Q Dianthus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.38% | -1.51% | |
| Form 10-K Dianthus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.11% | +1.32% | |
| Form 10-Q Dianthus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.51% | +7.62% | |
| Form 10-Q Dianthus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.47% | -1.26% | |
| Form 10-Q Dianthus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.22% | -3.68% | |
| Form 10-K Dianthus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +7.09% | +0.23% | |
| Form 10-Q Dianthus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.24% | -9.89% | |
| Form 10-Q Dianthus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.70% | +1.85% | |
| Form 10-Q Dianthus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.17% | -8.27% | |
| Form 10-K Dianthus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +11.95% | +9.20% |
Keep exploring
More DNTH: analyst actions → · SEC filings → · DNTH overview →